Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2533-2544

  Adelsman, Margaret A ^a   Huntley, Brenda K ^a   Maihle, Nita J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS LINKING REAGENT; DNA; LIGAND; MUTANT PROTEIN; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AVIAN ERYTHROBLASTOSIS ONCOVIRUS; CARCINOGENESIS; CELL TRANSFORMATION; CHICK EMBRYO; CONTROLLED STUDY; COVALENT BOND; DIMERIZATION; EMBRYO; ENDOTHELIUM CELL; ERYTHROBLAST; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TISSUE SPECIFICITY;

EID: 0029922880     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2533-2544.1996     Document Type: Article

References (67)

1. Anzano, M. A., D. Rieman, W. Prichett, D. F. Bowen-Pope, and R. Grieg. 1989. Growth factor production by human colon carcinoma cell lines Cancer Res. 49:2898-2904.
2. Bargmann, C. I., and R. A. Weinberg. 1988. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion EMBO J 7:2043-2052
3. Bargmann, C. I., and R. A. Weinberg. 1988. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc. Natl. Acad Sci. USA 85:5394-5398.
4. Bell, S. M., D. C. Connolly, N. J. Maihle, and J. L. Degen. 1993. Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases. Mol. Cell. Biol 123:5888-5897.
5. Berchuk, A., G. Rodriguez, A. Kamel, J. T. Soper, D. L. Clarke-Pearson, and R. C. Bast, Jr. 1990. Expression of epidermal growth factor receptor and HER2/neu in normal and neoplasic cervix, vulva, and vagina. Obstet. Gynecol. 76:381-387.
6. Berger, M. S., W. J. Gullick, C. Greenfield, S. Evans, B. J. Addis, and M. D. Waterfield. 1987. Epidermal growth factor receptors in lung tumours. J. Pathol. 152:297-307.
7. Beug, H., G. Doederlein, C. Freudenstein, and T. Graf. 1982. Erythroblast cell lines transformed by a temperature-sensitive mutant of avian erythroblastosis virus: a model system to study erythroid differentiation in vitro J. Cell. Physiol. Suppl. 1:195-207
8. Beug, H., and M. J. Hayman. 1984 Temperature-sensitive mutants of avian crythroblastosis virus: surface expression of the erbB product correlates with transformation. Cell 36:963-972.
9. Biswas, R., M. Basu, A. Sen-Majumdar, and M. Das. 1985. Intrapeptide autophosphorylation of the epidermal growth factor receptor: regulation of kinase catalytic function by receptor dimerization. Biochemistry 24:3795-3802
10. Brown, P. M., M. T. Debanne, S. Grothe, D. Bergsma, M. Caron, C. Kay, and M. D. O'Connor-McCourt. 1994 The extracellular domain of the epidermal growth factor receptor. Eur. J. Biochem. 225:223-233.
11. Carlberg, K., and L. Rohrschneider. 1994. The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor. Mol. Biol. Cell. 5:81-95.
12. Carpenter, C. D., H. A. Ingraham, C. Cochet, G. M. Walton, C. S. Lazar, J. M. Sowadski, M. G. Rosenfeld, and G. N. Gill. 1991. Structural analysis of the transmembrane domain of the epidermal growth factor receptor. J. Biol. Chem. 266:5750-5755.
13. Carter, T. H., and H.-J. Kung. 1994. Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit. Rev. Oncogenesis 5:389-428
14. Chantry, A. 1995. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors J. Biol. Chem. 270:3068-3073.
15. Connolly, D. C., S. L. Toutenhoofd, and N. J. Maihle. 1994. Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity. J. Virol 68:6804-6810.
16. Derynek, R., D. V. Goeddel, A. Ullrich, J. U. Gutterman, R. D. Williams, T. S. Bringman, and W. H. Berger. 1987. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47:707-712.
17. Di Fiore, P. P., J. H. Pierce, T. P. Fleming, R. Hazan, A. Ullrich, C. R. King, J. Schlessinger, and S. A. Aaronson. 1987. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH-3T3 cells Cell 15:1063-1070
18. Dou, Y., P. Hoffman, B. L. Huffman, and C. Carlin. 1992. Ligand-induced protein tyrosine kinase activity in living cells coexpressing intact EGF receptors and receptors with an extensive cytosolic deletion. J. Cell. Physiol. 153:402-407.
19. Flickinger, T. W. 1992. Characterization of a secreted, truncated receptor encoded by the avian c-erbB1 gene. Ph.D. thesis. Case Western Reserve University, Cleveland, Ohio.
20. Frank, S. J., G. Gilliland, and C. Van Epps. 1994 Treatment of IM-9 cells with human growth hormone (GH) promotes rapid disulfide linkage of the GH receptor. Endocrinology 135:148-156.
21. Freeman, M. R., R. Washecka, and L. W. K. Chung. 1989. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers. Cancer Res. 49:6221-6225.
22. Graham, F. L., and A. J. vao der Eb. 1973 A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
23. Hayman, M. J., and H. Beug. 1984. Identification of a form of the avian erythroblastosis virus erb-B gene product at the cell surface. Nature (London) 309:460-462.
24. Hayman, M. J., and P. J. Enrietto. 1991. Cell transformation by the epidermal growth factor receptor and v-erbB. Cancer Cells 3:302-307.
25. Hayman, M., G. Ramsay, K. Savin, G. Kitchner, T. Graf, and H. Beug. 1983. Identification and characterization of the avian erythroblastosis virus erbB gene product as a membrane glycoprotein. Cell 32:579-588.
26. Hughes, S. H., J. J. Greenhouse, C. J. Petropoulos, and P. Sutrave. 1987. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent reiroviral vectors. J. Virol. 61:3004-3012
27. Hurwitz, D. R., S. L. Emanuel, M. H. Nathan, N. Sarver, A. Ullrich, S. Felder, I. Lax, and J. Schlessinger. 1991. EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain. J. Biol. Chem. 266:22035-22043.
28. Jarrard, D. F., B. F. Blitz, R. C. Smith, B. L. Patai, and D. B. Rukstalis. 1994. Effect of epidermal growth factor on prostate cell line PC3 growth and invasion. Prostate 24:46-53.
29. Kashles, O., D. Szapary, F. Bellot, A. Ullrich. J. Schlessinger, and A. Schmidt. 1988. Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions. Proc. Natl. Acad. Sci. USA 85:9567-9571.
30. Kashles, O., Y. Yarden, R. Fischer, A. Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol 11:1454-1463.
31. Koland, J. G., and R. A., Cerione. 1988. Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism. J. Biol. Chem. 263:2230-2237.
32. Kris, R. M., I. Lax, W. Gullick, M. D. Waterfield, A. Ullrich, M. Fridkin, and J. Schlessinger. 1985. Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell 40:619-625.
33. Kwatra, M. M., D. D. Bigner, and J. A. Cohn. 1992. The ligand binding domain of the epidermal growth factor receptor is not required for receptor dimerization. Biochim. Biophys. Acta 1134:178-181
34. Lax, I., A. Johnson, R. Howk, J. Sap, F. Bellot, M. Winkler, A. Ullrich, B. Vennstrom, J. Schlessinger, and D. Givol. 1988. Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha. Mol. Cell. Biol. 8:1970-1978
35. Lax, I., A. K. Mitra, C. Ravera, D. R. Hurwitz, M. Rubinstein, A. Ullrich, R. M. Stroud, and J. Schlessinger. 1991. Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor J Biol. Chem. 266:13828-13833.
36. Lemmon, M. A., and J. Schlessinger. 1994 Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 19: 459-463.
37. Li, W., and J. Schlessinger. 1991. Platelet-derived growth factor (PDGF)-induced disulfide-linked dimerization of PDGF receptor in living cells. Mol Cell. Biol. 11:3756-3761.
38. Li, W., and E. R. Stanley. 1991. Role of dimerization and modification of the CSF-1 receptor in its activation and internalization during the CSF-1 response. EMBO J 10:277-288.
39. Maihle, N. J., and H.-J. Kung. 1988. C-erbB and the epidermal growth-factor receptor: a molecule with dual identity. Biochim. Biophys Acta 948:287-304.
40. Maihle, N. J., M. A. Raines, T. W. Flickinger, and H.-J. Kung. 1988. Proviral insertional activation of c-erbB. differential processing of the protein products arising from two alternate transcripts Mol Cell. Biol. 8:4868-4876.
41. McManus, M. J., D. C. Connolly, and N. J. Maihle. 1995. Tissue- and transformation-specific phosphotyrosyl proteins in v-erbB-transformed cells. J. Virol 69:3631-3638
42. Morris, G. L., and J. G. Dodd. 1990. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J. Urol. 143:1272-1274.
43. Moscovici, C., M. G. Moscovici, and H. Jiminez. 1977. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11:95-103.
44. Northwood, I., and R. J. Davis. 1988. Activation of the epidermal growth factor receptor tyrosine protein kinase in the absence of receptor oligomerization. J. Biol. Chem. 263:7450-7453.
45. Otter, T., S. M. King, and G. B. Witman. 1987. A two-step procedure for efficient electrotransfer of both high-molecular-weight (>400,000) and low-molecular-weight (<20,000) proteins Anal Biochem 162:370-377.
46. Privalsky, M. L., and J. M. Bishop. 1984. Subcellular localization of the v-erbB protein, the product of a transforming gene of avian erythroblastosis virus Virology 135:356-368.
47. c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. Proc Natl. Acad Sci. USA 89:1330-1334.
48. Raines, M. A., N. J. Maihle, C. Moscovici, M. G. Moscovici, and H.-J. Kung. 1988. Molecular characterization of three erbB transducing viruses generated during avian leukosis virus-induced erythroleukemia: extensive internal deletion near the kinase domain activates the fibrosarcoma- and hemangioma-inducing potentials of erbB. J. Virol. 62:2444-2452
49. Redemann, N., B. Holzmann, T. von Ruden, E. F. Wagner, J. Schlessinger, and A. Ullrich. 1992. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol. Cell. Biol. 12:491-498
50. Reidel, H., S. Massoglia, J. Schlessinger, and A. Ullrich. 1988. Ligand activation of overexpressed EGF receptors transforms NIH-3T3 mouse fibroblasts Proc. Natl. Acad. Sci. USA 85:1477-1481.
51. Santoro, M., F. Carlomagno, A. Romano, D. P. Bottaro, N. A. Dathan, M. Grieco, A. Fusco, G. Vecchio, B. Matoskova, M. H. Kraus, and P. P. Di Fiore. 1995. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381-383.
52. Schmidt, J. A., H. Beug, and M. J. Hayman. 1985. Effects of glycoprotein processing on the synthesis and biological activity of the erbB oncogene. EMBO J. 4:105-112.
53. Scotting, P., B. Vennstrom, M. Jansen, T. Graf, H. Beug, and M. J. Hayman. 1987. Common site of mutation in the erbB gene of avian erythroblastosis virus mutants that are temperature sensitive for transformation. Oncogene Res. 1:265-278.
54. Shu, H.-K. G., C.-M. Chang, L. Ravi, L. Ling, C. M. Castellano, E. Walter, R. J. Pelley, and H.-J. Kung. 1994. Modulation of erbB kinase activity and oncogenic potential by single point mutations in the glycine loop of the catalytic domain Mol. Cell. Biol. 14:6868-6878.
55. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
56. Staros, J. V. 1982. AT-Hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21:3950-3955.
57. neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol. 8:3969-3973.
58. Travers, M. T., P. J. Barrett-Lee, U. Berger, Y. A. Luqmani, J. C. Gazet, T. J. Powles, and R. C. Coombes. 1988. Growth factor expression in normal, benign, and malignant breast tissue. Br. Med. J. Clin. Res. 296:1621-1624.
59. Tuzi, N. L., D. J. Venter, S. Kumar, S. L. Staddon, N. R. Lemoine, and W. J. Gullick. 1991. Expression of growth factor receptors in human brain tumours. Br J. Cancer 63:227-233.
60. Velu, T. J., L. Beguinot, W. C. Vass, M. C. Willingham, G. T. Merlino, I. Pastan, and D. R. Lowy. 1987. Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene Science 238: 1408-1410.
61. Vivien, D., L. Attisano, J. L. Wrana, and J. Massague. 1995 Signaling activity of homologous and heterologous transforming growth factor-β receptor kinase complexes. J. Biol. Chem. 270:7134-7141.
62. Watowich, S. S., A. Yoshimura, G. D. Longmore, D. J. Hilton, Y. Yoshimura, and H. F. Lodish. 1992. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 89:2140-2144
63. Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. I. Greene. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (London) 339:230-231.
64. Wong, A. J., J. M. Ruppert, S. H. Bigner, C. H. Grzeschik, P. A. Humphrey, D. S. Bigner, and B. Vogelstein. 1992. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad Sci USA 89:2965-2969.
65. Yarden, Y., and J. Schlessinger. 1987. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26:1443-1451.
66. Yoshimura, A., G. Longmore, and H. F. Lodish. 1990. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature (London) 348:647-649.
67. Zhou, M., S. Felder, M. Rubinstein, D. R. Hurwitz, A. Ullrich, I. Lax, and J. Schlessinger. 1993. Real-time measurements of kinetics of EGF binding to soluble receptor monomers and dimers support the dimerization model for receptor activation. Biochemistry 32:8193-8198